Cbay stock forecast.
The consensus price target of analysts on Wall Street is $24.42, which implies an increase of 21.66% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $20.00 and $34.00 respectively. As a result, CBAY is trading at a discount of -77.73% off the target high and -4.55% off the low.
CymaBay Therapeutics Inc (CBAY) stock is trading at $11.76 as of 11:26 AM on Monday, Jul 3, a rise of $0.81, or 7.39% from the previous closing price of $10.95. The stock has traded between $10.95 and $11.77 so far today. Volume today is low. So far 1,522,720 shares have traded compared to average volume of 2,310,531 shares.We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...Xenon Pharmaceuticals Inc. 28.97. +0.24. +0.84%. Get CymaBay Therapeutics Inc (CBAY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.
Along with these comments, Rahimi gives CBAY an Overweight (i.e. Buy) rating, and her price target, set at $19, implies an 92% upside for the year ahead. (To watch Rahimi’s track record,5 brokers have issued 12-month price targets for X4 Pharmaceuticals' stock. Their XFOR share price targets range from $3.00 to $5.00. On average, they anticipate the company's share price to reach $3.50 in the next year. This suggests a possible upside of 359.6% from the stock's current price.
Sep 19, 2023 · CymaBay Therapeutics, Inc. (CBAY) share price prediction for 2023, 2024, 2025, 2026 and 2027. CBAY one year forecast. Cymabay Therapeutics stock monthly and weekly ...
Stock Price Forecast. The 22 analysts offering 12-month price forecasts for Thermo Fisher Scientific Inc have a median target of 519.50, with a high estimate of 600.00 and a low estimate of 435.00 ...View Coterra Energy Inc CTRA investment & stock information. Get the latest Coterra Energy Inc CTRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.97.32M. MSFT. 374.51. -1.16%. 29.21M. View today's Cymabay Therapeu stock price and latest CBAY news and analysis. Create real-time notifications to follow any changes in the live stock price.Based on 10 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $24.40 with a high forecast of $33.00 and a low forecast of $20.00. The average price target represents a 29.93% change from the last price of $18.78. Highest Price Target $33.00. Average Price Target $24.40.According to . 9 Wall Street analysts that have issued a 1 year CBAY price target, the average CBAY price target is $24.56, with the highest CBAY stock price forecast at $34.00 and the lowest CBAY stock price forecast at $15.00.
Find real-time CPG - Crescent Point Energy Corp stock quotes, company profile, news and forecasts from CNN Business.
1 brokerages have issued 12-month price targets for Tamarack Valley Energy's shares. Their TNEYF share price targets range from $2.25 to $4.25. On average, they anticipate the company's stock price to reach $3.30 in the next twelve months. This suggests a possible upside of 26.1% from the stock's current price.
7 brokers have issued 12-month price targets for Verastem's stock. Their VSTM share price targets range from $21.00 to $36.00. On average, they anticipate the company's share price to reach $29.71 in the next year. This suggests a possible upside of 362.1% from the stock's current price. View analysts price targets for VSTM or view top-rated ...Analyst projections state that BYND is forecast to be at a low of $3.00 and a high of $9.00. In order for the stock price to hit the forecast high, the stock would need to plunge -39.32% from its current level, while the stock would need to crash 53.56% from its current level to reach the projected low. Beyond Meat Inc (BYND) estimates and ...CBAY Stock Forecast: Positive Outlook and Analyst Consensus for CymaBay Therapeutics Inc. CBAY stock has been performing well in recent months, with positive forecasts from analysts. On June 30, 2023, the 10 analysts offering 12-month price forecasts for CBAY had a median target of $15.00, indicating a potential increase of 35.14% from the last ...Over the past 3 months, 14 analysts have published their opinion on CymaBay Therapeutics (NASDAQ:CBAY) stock. These analysts are typically employed by large Wall Street banks and tasked with ...Track Cymabay Therapeutics Inc (CBAY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors
Crescent Point Energy Corp () Stock Market info Recommendations: Buy or sell Crescent Point Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Crescent Point Energy share forecasts, stock quote and buy / sell signals below.According to present data Crescent Point Energy's CPG shares and potentially its …Analysts Offer Insights on Healthcare Companies: CymaBay Therapeutics (CBAY), Mersana Therapeutics (MRSN) and Verona Pharma (VRNA) November 8, 2023 TipRanks.(See CBAY stock forecast)Cerevel Therapeutics (CERE)The next Edelman choice is Cerevel, a company established in 2018 that specializes in the field of neuroscience. Cerevel's focus is on the ...Dec 1, 2023 · Their VKTX share price targets range from $19.00 to $37.00. On average, they predict the company's stock price to reach $30.25 in the next twelve months. This suggests a possible upside of 132.5% from the stock's current price. View analysts price targets for VKTX or view top-rated stocks among Wall Street analysts. According to CBAY; 1 in 1,000 women over the age of 40 live with PBC. Interested in CymaBay stock? Get a free CBAY Stock Research Report. Atara Bio (ATRA) Source: Shutterstock.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...(See CBAY stock forecast on TipRanks) AbSci Corporation . For the second penny stock we’ll look at, we’ll stick with the medical tech field – but look at a company with a different take on ...
The latest CymaBay Therapeutics stock prices, stock quotes, news, and CBAY history to help you invest and trade smarter. ... The 29 analysts offering price forecasts for CymaBay Therapeutics have ...
Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Spruce Biosciences Inc have a median target of 8.50, with a high estimate of 10.00 and a low estimate of 7.00. The median ...We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...View Tecnoglass Inc TGLS investment & stock information. Get the latest Tecnoglass Inc TGLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Future criteria checks 5/6. CymaBay Therapeutics is forecast to grow earnings and revenue by 59.3% and 61.1% per annum respectively. EPS is expected to …What happened. Shares of CymaBay Therapeutics ( CBAY 4.87%) were up more than 37% as of 11:15 a.m. ET on Friday. The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the CBAK Energy Technology share forecasts, stock quote and buy / sell signals below. According to present data CBAK Energy Technology's CBAT shares and potentially its market environment have been in bearish cycle last 12 months (if exists).People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Nov 8, 2023 · CBAY stock showed promising performance on November 8, 2023, according to data from CNN Money. The 12 analysts offering 12-month price forecasts for CymaBay Therapeutics Inc had a median target of 22.50, with a high estimate of 33.00 and a low estimate of 19.00.
The CymaBay Therapeutics stock forecast for tomorrow is $ 19.01, which would represent a -0.48% loss compared to the current price. In the next week, the price of CBAY is expected to decrease by -5.95% and hit $ 17.96. As far as the long-term CymaBay Therapeutics stock forecast is concerned ...
Stock Price Forecast. The 23 analysts offering 12-month price forecasts for Nokia Oyj have a median target of 4.39, with a high estimate of 7.60 and a low estimate of 3.49. The median estimate ...
VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.TNXP's stock price has decreased by -78.66% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 1 stock analyst, the 12-month stock price forecast for TNXP stock stock is $8.00, which predicts an increase of 1,453.40%.With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.According to CBAY; 1 in 1,000 women over the age of 40 live with PBC. Interested in CymaBay stock? Get a free CBAY Stock Research Report. Atara Bio (ATRA) Source: Shutterstock.Stock Price Forecast. The 1 analysts offering 12-month price forecasts for CBAK Energy Technology Inc have a median target of 1.80, with a high estimate of 1.80 and a low estimate of 1.80. The ...The current CymaBay Therapeutics [ CBAY] share price is $17.90. The Score for CBAY is 74, which is 48% above its historic median score of 50, and infers lower risk than normal. CBAY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.16 Wall Street analysts have issued 12 month price targets for Exelixis' stock. Their EXEL share price targets range from $18.00 to $32.00. On average, they anticipate the company's stock price to reach $25.44 in the next twelve months. This suggests a possible upside of 18.3% from the stock's current price. View analysts price …CBAY Stock Shows Promising Performance: Analysts Predict 38.63% Increase CBAY stock had a promising performance on November 6, 2023, based on the information provided by CNN Money. The 12 analysts offering 12-month price forecasts for CymaBay Therapeutics Inc have a median target of 22.50, with a high estimate of 33.00 and a low estimate of 19.00.Their PTGX share price targets range from $32.00 to $38.00. On average, they expect the company's share price to reach $35.25 in the next twelve months. This suggests a possible upside of 109.4% from the stock's current price. View analysts price targets for PTGX or view top-rated stocks among Wall Street analysts.97.32M. MSFT. 374.51. -1.16%. 29.21M. View today's Cymabay Therapeu stock price and latest CBAY news and analysis. Create real-time notifications to follow any changes in the live stock price.
Cymabay Therapeutics Stock Chart and Share Price Forecast, Short-Term "CBAY" Stock Prediction for Next Days and Weeks Walletinvestor.com Cymabay Therapeutics Inc (CBAY) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company's lead ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the CBAK Energy Technology share forecasts, stock quote and buy / sell signals below. According to present data CBAK Energy Technology's CBAT shares and potentially its market environment have been in bearish cycle last 12 months (if exists).As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Instagram:https://instagram. best app for tracking cryptocurrencypolestar nysehmsa dentalspirit vision insurance Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work. highest paying etfvalue of indian head buffalo nickel 6 analysts have issued 12 month price objectives for Spruce Biosciences' shares. Their SPRB share price targets range from $4.00 to $10.00. On average, they expect the company's share price to reach $7.67 in the next year. This suggests a possible upside of 463.7% from the stock's current price.Sector. Consumer Non-Durables. Industry. Food: Specialty/Candy. No executives to display. Corporate headquarters. --, --. Find real-time BROS - Dutch Bros Inc stock quotes, company profile, news ... insiders buying stock Nov 24, 2023 · A high-level overview of CymaBay Therapeutics, Inc. (CBAY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Is Cymabay Therapeutics (NASDAQ:CBAY) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, ...Discover historical prices for CBAY stock on Yahoo Finance. View daily, weekly or monthly format back to when CymaBay Therapeutics, Inc. stock was issued.